Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Osteoporosis
Is there any concern with starting romosozumab in a patient who is taking raloxifene for a history of breast cancer?
Related Questions
Is there any evidence regarding bone density gains/fracture reduction in the setting of treatment with romosozumab after a two year course of teriparatide?
What is your approach to management of methotrexate osteopathy?
How do you approach significant change in BMD in premenopausal patient on tamoxifen?
Is there a PTH elevation above which you would be hesitant to use an anabolic agent in a patient with osteoporosis and CKD stage 4 or 5?
How should we interpret DXA scans in patients with Ankylosing Spondylitis who have ankylosis of the spine?
What range of musculoskeletal complaints have you seen with romosozumab use?
What is your approach to management of severe osteoporosis in patients with advanced kidney disease?
After completing 12 months romosozumab, what is the next best treatment option for patients with severe osteoporosis, high risk for fracture, and normal kidney function?
Would you have concerns about combining romosuzumab and IVIG in a patient with dermatomyositis and osteoporosis?
What treatment options would you consider for a young patient with limited mobility, low bone mass and multiple vertebral compression fractures who is on dialysis for advanced kidney disease?
